Communiqués Aegerion Pharmaceuticals, Inc.

Actions

AEGR

US00767E1029

Produits pharmaceutiques

Temps Différé Nasdaq 22:00:00 29/11/2016			Varia. 5j.	Varia. 1 janv.
1,970 ^USD	+5,35%		+4,23%	-80,50%

06/11/14	AstraZeneca : relève encore son objectif de ventes 2014	RE
30/01/13	SANOFI : Un médicament de Sanofi contre une maladie rare approuvé aux USA	RE

Communiqués

29/11/16	Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc.	GL
17/11/16	Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) Receives Pricing Authorization in Japan	GL
03/11/16	Aegerion Pharmaceuticals Announces Third Quarter 2016 Financial Results	GL
24/10/16	Aegerion Pharmaceuticals : Research Reports Coverage on Biotech Stocks -- Merrimack Pharma, Aurinia Pharma, Aegerion Pharma, and TG Therapeutics	PR
28/09/16	Aegerion Pharmaceuticals' : JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	PU
28/09/16	Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules Approved in Japan for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)	GL
24/09/16	Aegerion Pharmaceuticals Observes Familial Hypercholesterolemia Awareness Day	GL
20/09/16	Aegerion Pharmaceuticals Appoints Remi Menes as Chief Commercial Officer	GL
09/08/16	Aegerion Pharmaceuticals Announces Second Quarter 2016 Financial Results	GL
20/07/16	Aegerion Pharmaceuticals Announces Cost Reduction Plans	GL
15/06/16	Aegerion Pharmaceuticals and QLT Inc. Agree to Strategic Merger	GL
07/06/16	Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program	GL
16/05/16	Aegerion Pharmaceuticals Announces First Quarter 2016 Financial Results	GL
13/05/16	Levi & Korsinsky, LLP Announces the Commencement of an Investigation into Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Aegerion, Inc.	BU
12/05/16	Aegerion Pharmaceuticals Announces Preliminary Agreements in Principle With DOJ and SEC Related to Ongoing Investigations	GL
11/05/16	Aegerion Pharmaceuticals to Announce First Quarter 2016 Financial Results on Monday, May 16	GL
06/05/16	Aegerion Pharmaceuticals : Grants Stock Options Under Inducement Program	PU
06/05/16	Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program	GL
11/04/16	Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program	GL
31/03/16	Aegerion Pharmaceuticals : célèbre la Journée mondiale de la lipodystrophie	GL
31/03/16	Aegerion Pharmaceuticals : Observes World Lipodystrophy Day	GL
10/03/16	Aegerion Pharmaceuticals : Grants Stock Options Under Inducement Program	PU
10/03/16	Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program	GL
02/03/16	Aegerion Pharmaceuticals : Announces Presentation at the Cowen & Company 36th Annual Health Care Conference	PU
02/03/16	Aegerion Pharmaceuticals Announces Presentation at the Cowen & Company 36th Annual Health Care Conference	GL